Date Filed | Type | Description |
08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
8-K
| Quarterly results |
07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/13/2023 |
4
| YEAMAN KEVIN J (President and CEO) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 18,060 shares
@ $87.8347, valued at
$1.6M
Sold 27,090 shares
@ $90, valued at
$2.4M
Exercised 18,060 options to buy
@ $42.98, valued at
$776.2k
Exercised 27,090 options to buy
@ $42.98, valued at
$1.2M
|
|
07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/24/2023 |
SD
| Form SD - Specialized disclosure report: |
05/18/2023 |
4
| YEAMAN KEVIN J (President and CEO) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 9,030 shares
@ $83.6491, valued at
$755.4k
Exercised 9,030 options to buy
@ $42.98, valued at
$388.1k
|
|
05/18/2023 |
4
| Revankar Shriram (SVP, Advanced Technology Group) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Paid exercise price by delivering 4,285 shares
@ $84.32, valued at
$361.3k
|
|
05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/16/2023 |
4
| Couling John D (SVP, Entertainment) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 278 shares
@ $83.87, valued at
$23.3k
|
|
05/10/2023 |
4
| SHERMAN MARK ANDREW (EVP, Gen. Counsel & Secretary) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 12,820 shares
@ $83.4653, valued at
$1.1M
Sold 2,180 shares
@ $84.3527, valued at
$183.9k
Exercised 11,118 options to buy
@ $45.5, valued at
$505.9k
Exercised 3,882 options to buy
@ $62.32, valued at
$241.9k
|
|
05/10/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 1,000 shares
@ $84.7, valued at
$84.7k
|
|
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/04/2023 |
8-K
| Quarterly results |
04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2023 |
4
| YEAMAN KEVIN J (President and CEO) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 26,375 shares
@ $81.0433, valued at
$2.1M
Sold 4,405 shares
@ $81.5299, valued at
$359.1k
Exercised 30,780 options to buy
@ $45.5, valued at
$1.4M
|
|
03/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.1% stake in Dolby Laboratories Inc. Class A |
02/28/2023 |
4
| Sud Anjali (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 8,873 shares
@ $81.9957, valued at
$727.5k
|
|
02/24/2023 |
4
| Pendleton Todd (SVP, Chief Marketing Officer) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Sold 28,701 shares
@ $82.3231, valued at
$2.4M
Exercised 5,250 options to buy
@ $64.6, valued at
$339.2k
Exercised 5,209 options to buy
@ $62.43, valued at
$325.2k
Exercised 7,927 options to buy
@ $68.4, valued at
$542.2k
|
|
02/14/2023 |
SC 13G
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reports a 8.5% stake in DOLBY LABORATORIES, INC. |
02/10/2023 |
8-K
| Quarterly results |
02/10/2023 |
SC 13G/A
| Clearbridge Investments, LLC reports a 4.8% stake in DOLBY LABORATORIES, INC. |
02/09/2023 |
4
| TEVANIAN AVADIS (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 Sold 1,392 shares
@ $83.64, valued at
$116.4k
|
|
02/09/2023 |
4
| Sud Anjali (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
4
| Segars Simon (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
4
| Prophet Tony A (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
4
| Dolby David (10% Owner) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
4
| Chau Micheline (Director) has filed a Form 4 on Dolby Laboratories, Inc.
Txns:
| Granted 3,296 shares
@ $0 |
|
02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.9% stake in Dolby Laboratories Inc. Class A |
|